Metraipolis › archive › dc_bae94b0ea945

Assessment of the efficacy of various neoadjuvant anti-HER2 targeted therapies combined with chemotherapy for HER2-positive breast cancer in the real-world… — Europe PMC PMID:41333210

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41333210
DOI
10.3389/fonc.2025.1673810
License (as archived)
solo-consultazione
Archived
2026-11-08T11:57:22.495Z
SHA-256 of the archived text
0e6ccbcf3b2d76180b1f007d68688484e98fe1620f9b0710a77def085f40f708
Stable URL of this page
https://metraipolis.com/documento/dc_bae94b0ea945

How to cite

Assessment of the efficacy of various neoadjuvant anti-HER2 targeted therapies combined with chemotherapy for HER2-positive breast cancer in the real-world… — Europe PMC PMID:41333210 — Europe PMC (en), https://europepmc.org/article/MED/41333210 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bae94b0ea945 (Metraipolis archive dc_bae94b0ea945, sha256 0e6ccbcf3b2d76180b1f007d68688484e98fe1620f9b0710a77def085f40f708)
BibTeX
@misc{dcbae94b0ea945,
  title = {Assessment of the efficacy of various neoadjuvant anti-HER2 targeted therapies combined with chemotherapy for HER2-positive breast cancer in the real-world… — Europe PMC PMID:41333210},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41333210},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bae94b0ea945; sha256 0e6ccbcf3b2d76180b1f007d68688484e98fe1620f9b0710a77def085f40f708},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41333210. Agents can read the archived copy with the MCP tool read_document.